X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs PANACEA BIOTECH - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD PANACEA BIOTECH ALEMBIC LTD/
PANACEA BIOTECH
 
P/E (TTM) x 76.8 80.9 95.0% View Chart
P/BV x 2.9 1.8 158.9% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
PANACEA BIOTECH
Mar-14
ALEMBIC LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs53149 35.5%   
Low Rs2982 35.6%   
Sales per share (Unadj.) Rs4.784.1 5.6%  
Earnings per share (Unadj.) Rs8.8-18.3 -47.9%  
Cash flow per share (Unadj.) Rs9.0-6.7 -134.4%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.783.7 33.1%  
Shares outstanding (eoy) m267.0361.25 436.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.71.4 633.6%   
Avg P/E ratio x4.7-6.3 -74.2%  
P/CF ratio (eoy) x4.6-17.2 -26.4%  
Price / Book Value ratio x1.51.4 107.3%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9627,074 154.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2381,449 16.4%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m1,2605,154 24.5%  
Other income Rs m264100 264.3%   
Total revenues Rs m1,5245,254 29.0%   
Gross profit Rs m83-766 -10.8%  
Depreciation Rs m61711 8.6%   
Interest Rs m01,503 0.0%   
Profit before tax Rs m285-2,881 -9.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m2,096-6 -36,775.4%   
Extraordinary Inc (Exp) Rs m-321,771 -1.8%   
Tax Rs m617 36.3%   
Profit after tax Rs m2,343-1,121 -208.9%  
Gross profit margin %6.6-14.9 -44.2%  
Effective tax rate %2.1-0.6 -367.1%   
Net profit margin %185.9-21.8 -854.4%  
BALANCE SHEET DATA
Current assets Rs m1,6893,810 44.3%   
Current liabilities Rs m4868,365 5.8%   
Net working cap to sales %95.4-88.4 -108.0%  
Current ratio x3.50.5 762.6%  
Inventory Days Days217156 139.3%  
Debtors Days Days8167 120.5%  
Net fixed assets Rs m1,62414,480 11.2%   
Share capital Rs m53461 871.3%   
"Free" reserves Rs m5,960903 660.0%   
Net worth Rs m7,4045,127 144.4%   
Long term debt Rs m1045,832 1.8%   
Total assets Rs m8,01019,433 41.2%  
Interest coverage x950.7-0.9 -103,727.9%   
Debt to equity ratio x01.1 1.2%  
Sales to assets ratio x0.20.3 59.3%   
Return on assets %29.32.0 1,489.3%  
Return on equity %31.6-21.9 -144.7%  
Return on capital %31.33.6 860.4%  
Exports to sales %2.924.5 12.0%   
Imports to sales %28.910.2 283.4%   
Exports (fob) Rs m371,264 2.9%   
Imports (cif) Rs m364525 69.3%   
Fx inflow Rs m371,539 2.4%   
Fx outflow Rs m365942 38.7%   
Net fx Rs m-328597 -54.9%   
CASH FLOW
From Operations Rs m346599 57.7%  
From Investments Rs m-48-438 10.9%  
From Financial Activity Rs m-301-303 99.5%  
Net Cashflow Rs m-3-141 2.1%  

Share Holding

Indian Promoters % 64.0 74.5 85.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.6 33.3%  
FIIs % 9.7 1.3 746.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 23.6 110.6%  
Shareholders   54,701 10,259 533.2%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  FDC LTD.  ASTRAZENECA PHARMA  BIOCON LTD  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS